Contact
Please use this form to send email to PR contact of this press release:
TRACON Doses First Patient in Phase 1/2 Study of TRC253 in Patients with Prostate Cancer
TO:
Please use this form to send email to PR contact of this press release:
TRACON Doses First Patient in Phase 1/2 Study of TRC253 in Patients with Prostate Cancer
TO: